| Product Code: ETC10600969 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, France saw a steady increase in human liver models import shipments, with top exporters being China, USA, Germany, UK, and other unspecified areas. The market remains competitive with low concentration, as indicated by the Herfindahl-Hirschman Index (HHI). Despite a healthy compound annual growth rate (CAGR) of 6.31% from 2020 to 2024, there was a significant decline in growth rate from 2023 to 2024 at -25.23%. This fluctuation suggests a dynamic market environment that may require closer monitoring and strategic adaptation for stakeholders in the liver models industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Human Liver Models Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Human Liver Models Market Revenues & Volume, 2021 & 2031F |
3.3 France Human Liver Models Market - Industry Life Cycle |
3.4 France Human Liver Models Market - Porter's Five Forces |
3.5 France Human Liver Models Market Revenues & Volume Share, By Model Type, 2021 & 2031F |
3.6 France Human Liver Models Market Revenues & Volume Share, By Technology Used, 2021 & 2031F |
3.7 France Human Liver Models Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.8 France Human Liver Models Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.9 France Human Liver Models Market Revenues & Volume Share, By Market Segment, 2021 & 2031F |
4 France Human Liver Models Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of liver diseases in France |
4.2.2 Growing demand for personalized medicine and drug development |
4.2.3 Technological advancements in liver modeling techniques |
4.3 Market Restraints |
4.3.1 High cost associated with human liver models |
4.3.2 Ethical concerns related to the use of human liver models in research |
4.3.3 Limited availability of skilled professionals in the field of liver modeling |
5 France Human Liver Models Market Trends |
6 France Human Liver Models Market, By Types |
6.1 France Human Liver Models Market, By Model Type |
6.1.1 Overview and Analysis |
6.1.2 France Human Liver Models Market Revenues & Volume, By Model Type, 2021 - 2031F |
6.1.3 France Human Liver Models Market Revenues & Volume, By 2D Hepatocyte Models, 2021 - 2031F |
6.1.4 France Human Liver Models Market Revenues & Volume, By 3D Liver Models, 2021 - 2031F |
6.1.5 France Human Liver Models Market Revenues & Volume, By Organ-on-a-chip, 2021 - 2031F |
6.1.6 France Human Liver Models Market Revenues & Volume, By Liver Spheroids, 2021 - 2031F |
6.2 France Human Liver Models Market, By Technology Used |
6.2.1 Overview and Analysis |
6.2.2 France Human Liver Models Market Revenues & Volume, By Cell Cultures, 2021 - 2031F |
6.2.3 France Human Liver Models Market Revenues & Volume, By 3D Bioprinting, 2021 - 2031F |
6.2.4 France Human Liver Models Market Revenues & Volume, By Microfluidic Platforms, 2021 - 2031F |
6.2.5 France Human Liver Models Market Revenues & Volume, By Stem Cell Culture, 2021 - 2031F |
6.3 France Human Liver Models Market, By Application Area |
6.3.1 Overview and Analysis |
6.3.2 France Human Liver Models Market Revenues & Volume, By Toxicology Testing, 2021 - 2031F |
6.3.3 France Human Liver Models Market Revenues & Volume, By Disease Modeling, 2021 - 2031F |
6.3.4 France Human Liver Models Market Revenues & Volume, By Drug Screening, 2021 - 2031F |
6.3.5 France Human Liver Models Market Revenues & Volume, By Regenerative Medicine, 2021 - 2031F |
6.4 France Human Liver Models Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 France Human Liver Models Market Revenues & Volume, By Drug Discovery, 2021 - 2031F |
6.4.3 France Human Liver Models Market Revenues & Volume, By Drug Development, 2021 - 2031F |
6.4.4 France Human Liver Models Market Revenues & Volume, By Biotech Companies, 2021 - 2031F |
6.4.5 France Human Liver Models Market Revenues & Volume, By Hepatology Studies, 2021 - 2031F |
6.5 France Human Liver Models Market, By Market Segment |
6.5.1 Overview and Analysis |
6.5.2 France Human Liver Models Market Revenues & Volume, By Research Laboratories, 2021 - 2031F |
6.5.3 France Human Liver Models Market Revenues & Volume, By Pharmaceutical, 2021 - 2031F |
6.5.4 France Human Liver Models Market Revenues & Volume, By R&D Applications, 2021 - 2031F |
6.5.5 France Human Liver Models Market Revenues & Volume, By Clinical Applications, 2021 - 2031F |
7 France Human Liver Models Market Import-Export Trade Statistics |
7.1 France Human Liver Models Market Export to Major Countries |
7.2 France Human Liver Models Market Imports from Major Countries |
8 France Human Liver Models Market Key Performance Indicators |
8.1 Number of research collaborations between pharmaceutical companies and academic institutions for liver model development |
8.2 Adoption rate of advanced liver modeling technologies in pharmaceutical and biotechnology companies |
8.3 Number of regulatory approvals for drugs developed using human liver models |
8.4 Rate of increase in research publications utilizing human liver models |
9 France Human Liver Models Market - Opportunity Assessment |
9.1 France Human Liver Models Market Opportunity Assessment, By Model Type, 2021 & 2031F |
9.2 France Human Liver Models Market Opportunity Assessment, By Technology Used, 2021 & 2031F |
9.3 France Human Liver Models Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.4 France Human Liver Models Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.5 France Human Liver Models Market Opportunity Assessment, By Market Segment, 2021 & 2031F |
10 France Human Liver Models Market - Competitive Landscape |
10.1 France Human Liver Models Market Revenue Share, By Companies, 2024 |
10.2 France Human Liver Models Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |